239 related articles for article (PubMed ID: 2958657)
1. [Significance of the thrombin-antithrombin III complex in the diagnosis of pulmonary embolism and deep venous thrombosis--comparison with fibrinopeptide A, platelet factor 4 and beta-thromboglobulin].
Blanke H; Praetorius G; Leschke M; Seitz R; Egbring R; Strauer BE
Klin Wochenschr; 1987 Aug; 65(16):757-63. PubMed ID: 2958657
[TBL] [Abstract][Full Text] [Related]
2. Indices of fibrinogen proteolysis and platelet activation during the resolution of pulmonary embolism.
Yudelman I
Thromb Haemost; 1987 Feb; 57(1):11-6. PubMed ID: 2954258
[TBL] [Abstract][Full Text] [Related]
3. Prethrombotic state due to hypercoagulability in patients with permanent transvenous pacemakers.
Ito T; Tanouchi J; Kato J; Nishino M; Iwai K; Tanahashi H; Hori M; Yamada Y; Kamada T
Angiology; 1997 Oct; 48(10):901-6. PubMed ID: 9342969
[TBL] [Abstract][Full Text] [Related]
4. A one-year follow-up study of plasma fibrinopeptide A and beta-thromboglobulin after deep vein thrombosis and pulmonary embolism.
van Hulsteijn H; Bertina R; Briët E
Thromb Res; 1982 Jul; 27(2):225-9. PubMed ID: 6182625
[No Abstract] [Full Text] [Related]
5. Diagnostic value of fibrinopeptide A and beta-thromboglobulin in acute deep venous thrombosis and pulmonary embolism.
van Hulsteijn H; Briët E; Koch C; Hermans J; Bertina R
Acta Med Scand; 1982; 211(5):323-30. PubMed ID: 6180602
[TBL] [Abstract][Full Text] [Related]
6. Hemostasis activation markers in acute renal failure.
Stefanidis I; Frank D; Maurin N
Ren Fail; 1998 Jan; 20(1):147-55. PubMed ID: 9509568
[TBL] [Abstract][Full Text] [Related]
7. Fibrinopeptide A, beta-thromboglobulin, and fibrin degradation products as screening test for the diagnosis of deep vein thrombosis.
Wojciechowski J; Olausson M; Korsan-Bengtsen K
Haemostasis; 1983; 13(4):254-61. PubMed ID: 6194049
[TBL] [Abstract][Full Text] [Related]
8. Plasma concentrations of fibrinopeptide A, fibrinogen fragment B beta 1-42 and beta-thromboglobulin following total hip replacement.
Lane DA; Ireland H; Wolff S; Grant R; Jennings S; Allen-Mersh T
Thromb Res; 1982 Apr; 26(2):111-8. PubMed ID: 6180501
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunoassay of platelet factor 4 and beta-thromboglobulin: development and application to studies of platelet release in relation to fibrinopeptide A generation.
Kaplan KL; Nossel HL; Drillings M; Lesznik G
Br J Haematol; 1978 May; 39(1):129-46. PubMed ID: 78721
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic antithrombin III administration during pregnancy immediately reduces the thrombin hyperactivity of congenital antithrombin III deficiency by forming thrombin-antithrombin III complexes.
Kario K; Matsuo T; Kodama K; Matsuo M
Thromb Res; 1992 Jun; 66(5):509-15. PubMed ID: 1523607
[TBL] [Abstract][Full Text] [Related]
11. Plasma beta-thromboglobulin, platelet factor 4, fibrinopeptide A, and other hemostatic functions during improved, short-term glycemic control in diabetes mellitus.
Rosove MH; Frank HJ; Harwig SS
Diabetes Care; 1984; 7(2):174-9. PubMed ID: 6203689
[TBL] [Abstract][Full Text] [Related]
12. Fibrinogen derivatives and platelet activation products in acute and chronic liver disease.
Hughes RD; Lane DA; Ireland H; Langley PG; Gimson AE; Williams R
Clin Sci (Lond); 1985 Jun; 68(6):701-7. PubMed ID: 2485273
[TBL] [Abstract][Full Text] [Related]
13. Fibrinopeptide A and beta thromboglobulin in patients with angina pectoris and acute myocardial infarction.
van Hulsteijn H; Kolff J; Briët E; van der Laarse A; Bertina R
Am Heart J; 1984 Jan; 107(1):39-45. PubMed ID: 6197872
[TBL] [Abstract][Full Text] [Related]
14. Studies of beta-thromboglobulin, platelet factor 4, and fibrinopeptide A in erythrocytosis due to cyanotic congenital heart disease.
Rosove MH; Hocking WG; Harwig SS; Perloff JK
Thromb Res; 1983 Jan; 29(2):225-35. PubMed ID: 6189239
[TBL] [Abstract][Full Text] [Related]
15. Molecular markers of hemostasis activation in nephrotic syndrome.
Sagripanti A; Cupisti A; Ferdeghini M; Pinori E; Barsotti G
Nephron; 1989; 51(1):25-8. PubMed ID: 2521695
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of fibrinopeptide A in surgery].
Fuwa S
Nihon Geka Gakkai Zasshi; 1984 Mar; 85(3):191-205. PubMed ID: 6236358
[TBL] [Abstract][Full Text] [Related]
17. Comparison of thrombin-antithrombin complex (TAT) levels and fibrinopeptide A following thrombin incubation of human plasma using hirudin as an inhibitor of TAT formation.
Haaland AK; Skjønsberg OH; Gravem K; Ruyter R; Godal HC
Thromb Res; 1991 Feb; 61(3):253-9. PubMed ID: 2028444
[TBL] [Abstract][Full Text] [Related]
18. Circadian variations of plasma levels of blood coagulation/fibrinolysis molecular markers in progressive systemic sclerosis (PSS).
Maeda M; Kachi H; Kitajima Y
J Dermatol Sci; 1996 Oct; 13(1):18-24. PubMed ID: 8902649
[TBL] [Abstract][Full Text] [Related]
19. Thrombosis in spinal cord injury.
Fujii Y; Mammen EF; Farag A; Muz J; Salciccioli GG; Weingarden ST
Thromb Res; 1992 Dec; 68(4-5):357-68. PubMed ID: 1290164
[TBL] [Abstract][Full Text] [Related]
20. Fibrin formation and platelet aggregation in patients with acute myocardial infarction: effects of intravenous and subcutaneous low-dose heparin.
Gallino A; Haeberli A; Hess T; Mombelli G; Straub PW
Am Heart J; 1986 Aug; 112(2):285-90. PubMed ID: 2426934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]